Enhanced AAV transduction across preclinical CNS models: A comparative study in human brain organoids with cross-species evaluationsMOLECULAR THERAPY NUCLEIC ACIDSIF6.12024-09-011OAAI
Development of CNS tropic AAV1-like variants with reduced liver-targeting following systemic administration in miceMOLECULAR THERAPYIF122024-03-012OAAI
PAK6-mediated phosphorylation of PPP2R2C regulates LRRK2-PP2A complex formationFRONTIERS IN MOLECULAR NEUROSCIENCEIF3.82023-12-183OAAI
A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, RespectivelyCELLSIF5.22022-03-173OAAI
Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulationNEUROBIOLOGY OF DISEASEIF5.62021-09-0110OAAI
Restoring the natural tropism of AAV2 vectors for human liverSCIENCE TRANSLATIONAL MEDICINEIF14.62020-09-0939OAAI
LRRK2 Phosphorylation, More Than an EpiphenomenonLRRK2磷酸化，不仅仅是一种现象FRONTIERS IN NEUROSCIENCEIF3.22020-06-1638OAAI
Investigating the neuroprotective effect of AAV-mediated β-synuclein overexpression in a transgenic model of synucleinopathySCIENTIFIC REPORTSIF3.92018-12-034OAAI
GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2HUMAN MOLECULAR GENETICSIF3.22017-04-2665OAAI
LRRK2 detection in human biofluids: potential use as a Parkinson's disease biomarker?BIOCHEMICAL SOCIETY TRANSACTIONSIF4.32017-02-1511OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向